A novel thromboxane A 2 receptor D304N variant that abrogates ligand binding in a patient with a bleeding diathesis

Andrew D. Mumford, Ban B. Dawood, Martina E. Daly, Sherina L. Murden, Michael D. Williams, Majd B. Protty, Jennifer C. Spalton, Mark Wheatley, Stuart J. Mundell, Steve P. Watson

Research output: Contribution to journalArticlepeer-review

55 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A novel thromboxane A 2 receptor D304N variant that abrogates ligand binding in a patient with a bleeding diathesis'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science